Search
Now showing items 1-1 of 1
Phase ii clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma
(Elsevier BV, 2012-09-01)
Based on promising preclinical efficacy of bortezomib in mesothelioma, a single-arm phase II trial (Ireland Cooperative Oncology Research Group 05-10 study), with Simon's two-stage design, was undertaken to assess efficacy ...